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Hypoxia inducible factor (HIF) is a transcription factor that acts in low-oxygen conditions. The cellular
response to HIF activation is transcriptional upregulation of a large group of genes. Some target genes
promote anaerobic metabolism to reduce oxygen consumption, while others ‘‘alleviate’’ hypoxia by acting
non-cell-autonomously to extend andmodify the surrounding vasculature. Although hypoxia is often thought
of as being a pathological phenomenon, the mammalian embryo in fact develops in a low-oxygen environ-
ment, and in this context HIF has additional responsibilities. This review describes how low oxygen and
HIF affect gene expression, cell behavior, and ultimately morphogenesis of the embryo and placenta.Introduction
Some 2.4 billion years ago, photosynthesis lead to the accumu-
lation of oxygen to levels that were likely toxic to many obligate
anaerobes. Organisms that could defend themselves against
oxidative stress, and at the same time utilize oxygen for energy,
survived and evolved. As time went on, a cellular requirement
for oxygen became critical, and animals developed a biochem-
ical response to low levels of oxygen. There are a number of
oxygen-sensing pathways that promote hypoxia tolerance by
activating transcription and inhibiting translation: the energy
and nutrient sensor mTOR, the unfolded protein response that
activates the endoplasmic stress response, and the nuclear
factor (NF)-kB transcriptional response (Perkins, 2007; Wouters
and Koritzinsky, 2008). In addition, the transcriptional response
mediated by hypoxia inducible factor (HIF) is a key feature of
the cellular response to hypoxia, and its role in mammalian
embryo development is the focus of this review.
HIF is a heterodimeric transcription factor consisting of two
subunits, Hifa and aryl hydrocarbon receptor nuclear transloca-
tor (Arnt; also called Hif1b) (Figure 1A); these factors interact via
two Per-Arnt-Sim (PAS) domains, bind DNA via N-terminal basic
helix-loop-helix (bHLH) domains, and activate transcription with
C-terminal transcriptional transactivation domains (TADs). In
mammals, Arnt is constitutively expressed, but the expression
and activity of Hifa are regulated by cellular oxygen concentra-
tion. In the absence of hypoxic stress—that is, at oxygen
concentrations above 5%—prolyl hydroxlase domain proteins
(Phd1–3) hydroxylate two proline residues of Hifa, enabling the
binding of the von Hippel-Lindau tumor suppressor protein
(Vhl). Vhl is the recognition component of an E3 ubiquitin-protein
ligase that targets Hifa for ubiquitylation and proteasomal
degradation (Ruas and Poellinger, 2005; Schofield and Ratcliffe,
2005). In addition, the factor inhibiting HIF (Fih) hydroxylates
an asparagine residue in the TAD, blocking binding of the
transcriptional coactivator CBP/p300 (Lisy and Peet, 2008).
Under low-oxygen conditions (less than 5%), the rate of prolyl
and asparaginyl hydroxylation is reduced, and as a result Hifa
accumulates, dimerizes with Arnt, and translocates to the
nucleus, where it binds DNA and associates with transcriptional
coactivators.DThere are three Hifa genes (Hif1a, Hif2a, and Hif3a) (Figure 1B).
Hif1a dimerizes with Arnt forming the HIF1 transcription factor,
and HIF2 is formed similarly via the association of Hif2a and
Arnt: both HIF1 and HIF2 activate transcription. Three Hif3a
isoforms (Hif3a, neonatal and embryonic PAS [NEPAS], and
inhibitory PAS protein [IPAS]) have been identified; Hif3a and
NEPAS have a single TAD, unlike Hif1a and Hif2a (which have
two), whereas IPAS lacks a TAD (Yamashita et al., 2008). Hif3a
and NEPAS negatively regulate HIF1 and HIF2 activity indirectly
by competing for available Arnt, and then only weakly activating
transcription. IPAS inhibits HIF1 and HIF2 activity through
a different mechanism by binding Hif1a and Hif2a and preventing
their heterodimerization with Arnt (Hara et al., 2001; Yamashita
et al., 2008). HIFs bind to the hypoxia responsive element
(HRE) (Ruas and Poellinger, 2005) to regulate the transcription
of some 200 genes in response to hypoxia (Elvidge et al.,
2006; Manalo et al., 2005). Currently, experimental evidence of
direct transcriptional activation by HIF activity exists for around
70 of these (Wenger et al., 2005), and some target genes specif-
ically activated by HIF1 or HIF2 have been identified (Aprelikova
et al., 2006; Elvidge et al., 2006; Hu et al., 2003).
The functional repertoire of the HIF transcription system
expanded with the increase in complexity and size that occurred
during animal speciation. In the nematode worm Caenorhabditis
elegans, where oxygen delivery occurs by diffusion, hypoxia is
resisted through reduced energy expenditure and a HIF-depen-
dent switch to anaerobic metabolism, achieved via upregulated
expression of glucose transporters and glycolytic enzymes.
Simple diffusion of oxygen is inadequate in larger organisms,
where an oxygen delivery system is required (Fisher and Burgg-
ren, 2007). The fruit fly Drosophila melanogaster, for example,
has co-opted the HIF transcription network to facilitate the
formation of the oxygen-delivering tracheal system (Gorr et al.,
2006). Interestingly, the hypoxia-responsive Drosophila Hif1a
homolog (sima) is not required for formation of the tracheal
system. Instead trachealess, which is not induced by hypoxia,
dimerizes with the Arnt homolog (tango) and specifies tracheal
cells. The further increase in complexity of vertebrates, and the
evolution of endotherms (birds and mammals), necessitated an
efficient solution to the mounting demands for oxygen andevelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 755
Figure 1. HIF Regulation under Aerobic and Hypoxic
Conditions
(A) Oxygen is required for the hydroxylation of two proline residues of
Hifa by prolyl hydroxylase domain proteins (Phd1–3). Proline hydrox-
ylation is necessary for binding of the von Hippel-Lindau tumor
suppressor protein (Vhl) and ubiquitin-mediated proteosomal degra-
dation. Oxygen is also a cofactor for hydroxylation of an asparagine
residue in the transcriptional activation domain of Hifa by the aspara-
gine hydroxylase factor inhibiting HIF (Fih). Asparagine hydroxylation
prevents the binding of the transcriptional coactivator CBP/p300.
Hypoxia inhibits proline and asparagine hydroxylation, which allows
Hifa to accumulate, dimerize with Arnt, form the HIF transcription
complex, and activate transcription of target genes that carry func-
tional hypoxia responsive elements (HREs).
(B) Arnt (Hif1b) dimerizes with Hif1a or Hif2a to form HIF1 and HIF2,
respectively, which activate transcription (++). Hif3a encodes for three
isoforms (Hif3a, NEPAS, and IPAS). Dimerization of Arnt and Hif3a or
NEPAS forms HIF3 or HIF3NEPAS, which activate transcription to a
lesser extent (+). IPAS binds Hif1a or Hif2a, preventing interaction
with Arnt and inhibiting transcription (). NEPAS, neonatal and embry-
onic PAS; IPAS, inhibitory PAS protein. (*) denotes protein stabilized
by hypoxia.
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increasing the capacity of the cardiovascular system, as excel-
lently reviewed by Fisher and Burggren (2007). Despite the effi-
cacy of the cardiovascular system in sensing and ameliorating
systemic low oxygen, cells can still experience hypoxia, depend-
ing on their proximity to blood vessels, tissue architecture, and
rate of oxygen consumption. When hypoxic conditions occur,
HIF transcriptionally activates genes that, depending on the
context, are involved in energy metabolism, autophagy, transla-
tion inhibition, erythropoiesis, and angiogenesis. These genes
promote tolerance of hypoxia by decreasing the cellular require-
ment for oxygen and increasing the supply of oxygen (Anderson
et al., 2009; Kaelin and Ratcliffe, 2008).
In mammals the HIF transcription system is not only involved in
tolerance of, and rescue from, pathological hypoxia. Normal
mammalian development occurs in a hypoxic environment,
and here HIF activates genes that regulate cellular events, so
hypoxia and HIF are therefore responsible for aspects of devel-
opmental morphogenesis. Oxygen concentrations range from
1% to 5% (pO2 0.5–30 mmHg) in the uterine environment
(Okazaki and Maltepe, 2006). Although the placenta and the
embryonic cardiovascular system are conduits for oxygen
delivery within the developing conceptus, they too are forming
and so conditions of low cellular oxygen prevail. Cells low in
oxygen can be identified using 2-nitromidazole drugs, such as
pimonidazole and EF5, which bind protein and DNA at %2%
oxygen (Mahy et al., 2003). There is significant colocalization of
drug binding and Hif1a protein expression, demonstrating that756 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.these drugs are a useful marker of regions experiencing
cellular hypoxia. In the mouse embryo, cells low in oxygen
(%2%) are widespread (Lee et al., 2001; Pringle et al.,
2007) until the maternal and fetal blood interface around
midgestation. After this time cells low in oxygen are still
consistently detected in specific regions of the embryo,
including the developing heart, gut, and skeleton
(Figure 2). In part this is probably because the developing
vasculature lacks the capacity to keep pace with the
phenomenal growth and energy demands of the embryoduring the second half of gestation. The HIF transcription system
is used in embryos to enable cellular survival in a low-oxygen
environment. However, during evolution HIF has been co-opted
to direct many other cellular processes that ultimately enable the
embryo to survive after birth.
A true appreciation of the role of HIF in the cellular response to
low oxygen levels during embryonic development is still unfold-
ing; its effects on stem cell function and on angiogenesis have
been recently reviewed by Simon and Keith (2008) and Fraisl
et al. (2009). Here I describe its impact on development of the
placenta, heart, and bone in mouse. Through effects on cell
proliferation, cell differentiation, and cell behavior, the response
to low oxygen (or physiological hypoxia) ultimately contributes to
embryonic morphogenesis. Throughout this review, the term
‘‘hypoxia’’ will be used to describe the naturally low (<2%) oxygen
concentrations experienced during normal development. This
type of hypoxia is distinct from ‘‘nonphysiological hypoxia,’’
which can result from cardiovascular demise, placental insuffi-
ciency, or environmental insult.
Oxygen and HIF Activity Impact Placental Development
The placenta is a remarkable amalgamation of tissues derived
from extraembryonic cells of the conceptus and the maternal
decidua (uterine lining). The past decade has seen an astounding
increase in our understanding of placental development, and in
our appreciation of this organ’s role in normal embryonic devel-
opment. These advances are covered in excellent review articles
(Simmons et al., 2007; Watson and Cross, 2005).
Figure 2. Cellular Hypoxia in the Embryo
and Heart
Pimonidazole (2-nitromidazole compound) binds
DNA and protein at <2% oxygen and identifies
hypoxic cells (black) in parasagittal sections in
the mouse embryo at E14.5 (A), E11.5 heart (B),
and E11.5 atrioventricular endocardial cushion
(C). Hypoxic cells are present at E14.5 in the
heart (h), gut (g), lung (l), midbrain (mb), pituitary
(p), spinal cord (sc), sternum (s), tongue (t),
and vertebra (v); and at E11.5, also in the inter-
ventricular septum (ivs), cushion-associated
myocardium (m) of the outflow tract (OFT), and
atrioventricular canal (AVC). a, atrium; mes,
mesenchymal cells; ven, ventricle. (*) denotes
torn tissue between the myocardium and mesen-
chymal cells of the developing endocardial
cushion. These data (unpublished) support and
extend that published by Ream et al. (2008) and
Xu et al. (2007). Scale bar: 108 mm (A), 130 mm
(B), 13 mm (C).
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and 14.5 of gestation, and key features of its morphogenesis are
summarized in Figure 3. In mouse at E3.5 the conceptus (blasto-
cyst) consists of two cell lineages: the trophectoderm, which
gives rise to trophoblasts that constitute the placenta, and the
inner cell mass (ICM), which gives rise to the embryo, allantois
(component of umbilical cord), and fetal vasculature of the
placenta. At embryo implantation (E4.5), trophectoderm over-
laying the ICM proliferates and produces the extraembryonic
ectoderm, while mural trophectoderm not associated with the
ICM ceases to divide and undergoes endoreduplication, forming
primary parietal trophoblast giant cells (TGCs) that are polyploid.
After embryo implantation a secondary wave of parietal TGCs
forms, and these surround the entire conceptus and facilitate
implantation and invasion into the decidua. As development
proceeds the extraembryonic ectoderm expands to form the
chorion and ectoplacental cone (EPC); these tissues provide
a pool of diploid trophoblast progenitor cells that support further
placental development.
At maturity, the murine placenta consists of three fetal layers
(Figure 3): the labyrinthine layer is proximal to the embryo, and
is where fetal blood vessels and trophoblast-lined maternal
blood sinuses are brought into proximity to enable nutrient and
gaseous exchange. Next is the spongiotrophoblast layer, which
provides structural support to the expanding labyrinthine layer
and is a source of trophoblast subtypes (Figure 4). The parietal
TGC layer then lies distal to the spongiotrophoblasts and
borders the decidua. The parietal TGCs facilitate embryo implan-
tation and decidua invasion, and produce hormones to maintain
the pregnancy. Fetal development requires that the placenta is
integrated with the maternal decidua. Thus spiral arteries direct
maternal blood from the decidua to the labyrinthine layer via
central canals, and this organization requires decidual invasion
by spiral artery TGCs. Glycogen trophoblasts also invade the
decidua and are postulated to act as a source of stored energy
(Coan et al., 2006). Because multiple cell types, derived fromDthe conceptus as well as the mother, interact to produce a
functional placenta, it is not surprising that at least 85 genes
are required in mouse for normal placental formation and func-
tion (Watson and Cross, 2005).
One of the main functions of the placenta is to bring oxygen-
ated maternal blood into proximity with deoxygenated fetal
blood; paradoxically, however, the placenta develops in a low-
oxygen environment and some placental cells remain hypoxic
(%2% oxygen) later in development despite the flow of oxygen-
ated maternal blood to the placenta (Okazaki and Maltepe, 2006;
Withington et al., 2006). Hypoxic cells, and cells expressing
Hif1a and Hif2a, are present in the decidua and placenta
between E6.5–14.5 (Pringle et al., 2007; Scha¨ffer et al., 2006;
Withington et al., 2006).
HIF activity is required for normal development of the placenta,
and loss of Hif1a, both Hif1a and Hif2a, or Arnt in mouse
causes a catastrophic failure in placenta formation, resulting in
embryo lethality by E10.5 (Abbott and Buckalew, 2000; Adelman
et al., 2000; Cowden Dahl et al., 2005a; Kozak et al., 1997). Key
features of the placental defects (Table 1 and discussed below)
include: reduced or lessened interaction between the embryo
and forming placenta (chorioallantoic interaction); reduced
development of the labyrinthine layer; limited vascularization of
the placenta; overarching disruption of trophoblast differentiation
with the absence of syncytiotrophoblasts; a dramatic reduction in
spongiotrophoblasts; and greater numbers of TGCs. These
placental defects can be placed in context with our current
understanding of the effects of hypoxia on trophoblast prolifera-
tion, differentiation, and gene expression.
HIF Regulates Branching Morphogenesis and Fetal
Vascularization of the Placenta
Development of the labyrinthine layer of the placenta requires
interaction between the allantois, which is the source of the
fetal vasculature of the placenta, and the chorion, which is the
source of diploid trophoblasts (Figures 3 and 4). This interaction
involves reciprocal signaling between the allantois, whichevelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 757
Figure 3. Placental Development in Mouse
Two distinct cell lineages of the blastocyst, the
ICM and the trophectoderm, contribute to the
placenta. The maternal decidua surrounds the
conceptus (not depicted), and primary parietal
trophoblast giant cells (P-TGC; oval-shaped) facil-
itate the invasion of the decidua as placental
development proceeds. At E8.5 cells of the ecto-
placental cone (EPC) are interspersed with sinuses
lined with sinusoidal TGCs (S-TGC) and filled with
maternal blood. The chorion and allantois interact;
this induces folding of the chorion, which facili-
tates branching morphogenesis and vasculariza-
tion of the developing labyrinthine layer. Tropho-
blasts of the chorion and EPC proliferate and
differentiate into trophoblast subtypes (see
Figure 4). At E9.5 spongiotrophoblasts (spongio-)
and secondary P-TGC layers are evident as the
labyrinthine layer expands. At E10.5 the density
of fetal blood vessels and maternal blood sinuses
increases in the labyrinthine layer. Fetal endothe-
lial cells, syncytiotrophoblasts, and S-TGCs sepa-
rate fetal and maternal bloods.
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and it is essential for buckling of the chorion, for its penetration
by fetal vascular endothelial cells, and for diploid trophoblast
proliferation (Stecca et al., 2002). Further elaboration of the
fetal vasculature requires branching morphogenesis of the
trophoblast-derived epithelium and angiogenesis by fetal
vascular endothelial cells.
HIF activity is required for effective chorioallantoic interaction
and branching morphogenesis. Loss of HIF1a activity disrupts
chorioallantoic interaction in 31% of null embryos, and accord-
ingly fetal blood vessels are unable to invade the trophoblasts
(Table 1). In these cases, no overt morphological deficiency in the
allantois or chorion is evident, suggesting that HIF affects molec-
ular components, such as integrins and their ligands (Itga4,
Cyr61, and Vcam1), that are required for the interaction itself
(Watson and Cross, 2005). In the majority of null embryos, chorio-
allantoic interaction does occur, but vascularization of the devel-
oping labyrinthine layer is reduced. This suggests that branching
morphogenesis of the trophoblasts is impaired, that angiogen-
esis by fetal vascular endothelial cells is defective, or both.758 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.The molecular mechanism by which
HIF affects chorioallantoic fusion and
fetal vascularization is unclear, but at
least two avenues seem worthy of further
investigation. First, chorioallantoic inter-
action and branching morphogenesis
rely on integrins (Itga4, Itga5, Itgb8), and
components of their signal transduction
pathway (Sos1, Raf1, Map3k3/Mekk3,
Map2k1/Mek1, Mapk1/Erk2, Mapk7/
Erk5, and Mapk14/p38alpha MAPK)
(Watson and Cross, 2005). Hypoxia
induces the expression of some integrins
and their ligands including Itga5 (Cowden
Dahl et al., 2005b; Kilburn et al., 2000),
and Hif1a is stabilized by Mapk1 and
Mapk3-induced phosphorylation (Berra
et al., 2000). Second, vascularization ofthe placenta depends on angiogenesis, and some HIF target
genes such as Kdr (Vegfr2), Angiopoietin1 (Ang1), and Tek
(Tie2) are reduced in Arnt null placentas (Abbott and Buckalew,
2000). It will be interesting to discover through further investiga-
tion whether either or both of these pathways are involved in
mediating the role that HIF plays in placental angiogenesis.
HIF Is Required for Trophoblast Proliferation
and Differentiation
Trophoblasts of the chorion and EPC proliferate and differentiate
into distinct trophoblast subtypes that populate the different
layers of the placenta and play essential roles in its develop-
ment and function. Cellular hypoxia is present as the placenta
develops, and HIF activity is required for both trophoblast
proliferation and the formation of specific cell subtypes. There
are numerous differentiated trophoblast subtypes: diploid
trophoblasts (spongiotrophoblasts and glycogen trophoblasts);
diploid and multinucleated trophoblasts (syncytiotrophoblasts);
and the polyploid TGCs (parietal, spiral artery, canal, and sinu-
soidal) (Figures 3 and 4) (Simmons et al., 2007). The maternal
decidua is invaded by spiral artery TGCs and glycogen
Figure 4. Trophoblast Lineages and the
Effects of Hypoxia on Their Formation
Schematic diagram of the mouse placenta
(decidua not shown) from E8.5–14.5 depicting
lineage relationships of trophoblasts (black
arrows). Diploid trophoblasts proliferate (semi-
circle with arrow) or differentiate (arrow) into
various trophoblast subtypes. Hypoxia facilitates
chorioallantoic attachment (+). Hypoxia induces
Mash2 expression, supporting proliferation of
diploid trophoblasts. Hypoxia inhibits Gcm1 and
Cyp19 expression. Normoxia (absence of hypoxia)
allows Gcm1, synctin-a/b, and Cyp19 expression;
this supports the differentiation of syncytiotropho-
blasts. Green arrows show stimulatory effects; red
lines, inhibitory effects. The outer cells are primary
parietal trophoblast giant cells (TGC; oval-
shaped). Syncytio-, syncytiotrophoblast; S-TGC,
sinusoidal TGC; C-TGC, canal TGC; spongio-,
spongiotrophoblast; glycogen, glycogen tropho-
blast; P-TGC, parietal TGC; Spa-TGC, spiral artery
TGC. (Adamson et al., 2002; Adelman et al., 2000;
Cowden Dahl et al., 2005a; Simmons and Cross,
2005; Simmons et al., 2007).
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Spiral artery TGCs replace the maternal endothelial cells in the
lumen of the spiral arteries and facilitate the funneling of
maternal blood to the labyrinthine layer. Glycogen trophoblasts
accumulate glycogen and localize near the spiral arteries, and
their lysis prior to term may provide a substantial energy source
for the final phase of fetal growth (Coan et al., 2006). Parietal
TGCs line the wall of the implantation site separating the EPC
from the decidua. They are formed in two waves—the primary
parietal TGCs from mural trophectoderm, and the secondary
parietal TGCs from the EPC and spongiotrophoblasts.
These parietal TGCs are invasive and mediate embryo implanta-
tion; they also produce hormones that regulate the maternal
endocrine and immune systems and promote blood flow to
the implantation site. Spongiotrophoblasts, derived from the
EPC, lie adjacent to the parietal TGCs. They provide structural
support, secrete peptide hormones, and give rise to spiral artery
TGCs, parietal TGCs, and glycogen trophoblasts. Canal TGCs
line the central canals that bring maternal blood from the
decidua to the labyrinthine layer, and are derived from the
EPC and spongiotrophoblasts. A layer of fetal vascular endothe-
lial cells (derived from the allantois), a layer of sinusoidal TGCs,
and two layers of syncytiotrophoblasts separate the maternal
and fetal blood spaces in the labyrinthine. Sinusoidal TGCs,
which are derived from the EPC, line the maternal blood spaces;
they secrete hormones and are likely to have an endocrine func-
tion. The syncytiotrophoblasts, also derived from the EPC,
mediate trophic exchange between the mother and the fetus
(Dupressoir et al., 2009).
Trophoblasts that border the decidua and labyrinthine layer
(spongiotrophoblasts and parietal TGCs) are hypoxic from
E9.5–14.5 (Pringle et al., 2007; Scha¨ffer et al., 2006; Withington
et al., 2006). During this time Hif1a and Hif2a transcripts are
localized to these border cells. Hif1a is also highly expressed
in the developing labyrinthine layer and Hif2a in the decidua. In
addition, Hif1a protein is expressed in the decidua, spongiotro-
phoblasts, and parietal TGCs (Pringle et al., 2007; Scha¨ffer
et al., 2006; Withington et al., 2006).DReduced HIF activity has a profound effect on the production
of trophoblast subtypes; there are fewer spongiotrophoblasts
and syncytiotrophoblasts, and an increase in TGCs (Table 1).
These changes in trophoblast composition occur in the 69% of
Hif1a null mutants that do undergo chorioallantoic interaction,
indicating that HIF activity is also required at this later stage of
placental development. A number of studies have indicated
that the effect on trophoblast differentiation results from
fewer diploid progenitor trophoblasts, and that proliferation
of the progenitor diploid trophoblasts (resident in the chorion
and EPC) intrinsically require HIF activity. In these studies,
trophoblast stem (TS) cells have been a valuable tool for deter-
mining the roles that oxygen concentration and HIF activity
have in trophoblast proliferation and differentiation. TS cells,
although most readily derived from the blastocyst, are resident
in the chorion. They can be propagated in culture, and differen-
tiate into trophoblast subtypes (spongiotrophoblasts, TGCs,
syncytiotrophoblasts) (Cowden Dahl et al., 2005a). Thus TS
cells behave similarly to diploid progenitor trophoblasts. In
the absence of Arnt, TS cells have a proliferation deficiency;
conversely, low levels of oxygen promote proliferation of wild-
type TS cells (Adelman et al., 2000). These results indicate that
HIF activity regulates TS cell proliferation and by inference,
that of diploid progenitor trophoblasts also.
In addition to stimulating the proliferation of progenitor tropho-
blasts, oxygen concentration and HIF activity also direct the
differentiation of certain trophoblast subtypes. For example,
there is evidence supporting a more direct role of HIF activity
in spongiotrophoblast differentiation. In vitro, under low-oxygen
conditions, differentiating TS cells have augmented expression
of spongiotrophoblast markers such as Mash2 and Tpbpa
(Adelman et al., 2000; Cowden Dahl et al., 2005a; Maltepe et al.,
2005). In addition, TS cells lacking Hif1a/Hif2a or Arnt are virtu-
ally incapable of differentiating into Tpbpa-expressing spongio-
trophoblasts (Adelman et al., 2000; Cowden Dahl et al., 2005a;
Maltepe et al., 2005). Therefore, trophoblast progenitors seem
to require the HIF-mediated hypoxic response to drive spongio-
trophoblast production in the developing placenta (Figure 4).evelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 759
Table 1. Placental Defects in Mice Lacking Components of the HIF Transcription Complex
Gene Allele (Type) Mouse Model
(Cells Affected)
Lethal Key Aspects of
Placenta Phenotype
Marker Gene
Expression
HIF Target Gene
Expression
Reference
Hif1a HIf1atm1Pec
(null)
homozygous
(conceptus)
E10.5 no chorioallantoic
attachment or
vascularization
(31%), reduced
vascularization and
spongiotrophoblasts
(69%)
mPl1, Hand1, LIMK,
Ada, Pl1, Mmp9,
Id2, VE-cadherin,
Tpbp, Mash2
Vegfa, Flt1, Flk1 Cowden Dahl
et al., 2005
Hif1a
Hif2a
Hif1atm1Pec
Epas1tm1Pec
(null)
homozygous
(conceptus)
E10.5 no chorioallantoic
attachment or
vascularization,
reduced
spongiotrophoblasts
and syncytiotrophoblasts
mPl1, Tpbp, Tfeb - Cowden Dahl
et al., 2005
Arnt Arnttm1Oha
(null)
homozygous
(conceptus)
E9.5–10.5 E9.5 small chorioallantoic
plate, reduced
vascularisation,
and cavities in
labyrinth
Pecam1 - Kozak
et al., 1997
Arnt Arnttm1Mcs
(null)
homozygous
(conceptus)
E9.5–10.5 chorionic plate
present, reduced
vascularization
and spongiotrophoblasts,
increased TGC
Mash2 (E8.5), mPl1,
4311, Tgfb3 (E9.5)
Tgfb3 (E9.5) Adelman
et al., 2000
Arnt Arnttm1Mcs
(null)
chimera
(embryo and
vasculature
of placenta)
E9.5–10.5 E9.7 placenta normal
but yolk sac defect
retained
Tgfb1, Glut3, Mash2,
p21, Tfeb, Pdgfb, Pdgfrb,
Plf, Plfr, Pgf, CSF-1R,
Glut1, Vegf,
Tie2, Tgfb3
Adelman
et al., 2000
Arnt Arnttm1Oha
(null)
homozygous
(conceptus)
E10.5 reduced
vascularization
- Vegfa, Vegfr2,
Tie2, Ang1
Abbott
et al., 2000
Arnt Arnttm1Mcs
(null)
homozygous
(conceptus)
no chorioallantoic
attachment,
reduced
spongiotrophoblasts
and syncytiotrophoblasts
mPl1, Tpbp, Tfeb - Cowden Dahl
et al., 2005
Allele symbols are standard (http://www.informatics.jax.org). Conceptus includes embryonic and extraembryonic tissues. The publications use
various gene names; Flt1 (Vegfr1), Kdr (Vegfr2, Flk1), Tek (Tie2), and 4311 (Tpbpa). Gene expression level: equal, Roman lightface text; up, boldface;
down, italics. Initial analysis of conceptuses homozygous for the Arnttm1Mcs null allele did not describe placental defects (Maltepe et al., 1997). Hif2a
(Epas) null conspectuses do not have placental defects (Tian et al., 1998; Cowden Dahl et al., 2005a; Peng et al., 2000).
Developmental Cell
ReviewAlthough loss of HIF activity leads to an increase in the number
of TGCs in the placenta, two lines of in vitro evidence suggest that
this defect is unlikely to reflect a direct role of HIF in TGC differen-
tiation. First, TS cells grown in low-oxygen conditions do not pref-
erentially differentiate into TGCs, given that they express reduced
levels of Hand1 (required for TGC differentiation) and proliferin
(a TGC marker) (Cowden Dahl et al., 2005a). Second, TS cells
null for Hif1a/Hif2a or Arnt do not overproduce TGCs; indeed,
expression of TGC markers (proliferin and placental lactogen1)
is greatly diminished (Cowden Dahl et al., 2005a; Maltepe et al.,
2005). Therefore, the most parsimonious explanation for the
increase in TGCs in placentas that lack Hif1a/Hif2a or Arnt is
that diploid trophoblasts differentiate into parietal TGCs because
they are unable to form spongiotrophoblasts.
Lack of HIF activity results in the loss of syncytiotrophoblasts
in the placenta, but this effect is unlikely to be direct and instead
is probably a result of the lack of progenitor trophoblasts caused760 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.by their diminished proliferation, as discussed above. Syncytio-
trophoblasts are reduced in placentas lacking Hif1a/Hif2a or
Arnt (Cowden Dahl et al., 2005a), suggesting that hypoxia and
HIF might be required for syncytiotrophoblast production.
However, this is unlikely to be the case because TS cells cultured
in low oxygen do not form syncytiotrophoblasts, and their
production from TS cells is in fact enhanced in the absence of
Hif1a/Hif2a or Arnt (Cowden Dahl et al., 2005a).
The molecular framework that underpins progenitor tropho-
blast proliferation and syncytiotrophoblast differentiation is
beginning to emerge (Figure 4). During trophoblast proliferation,
low oxygen induces the expression of Mash2 and cyclin B, which
promote cell cycle progression in diploid progenitor tropho-
blasts; it also inhibits the expression of Gcm1, which promotes
cell cycle exit (Hughes et al., 2004; Knerr et al., 2005). For syncy-
tiotrophoblast formation, low oxygen and Mash2 repress the
expression of Cyp19, which encodes the aromatase P450 that
Developmental Cell
Reviewpromotes syncytiotrophoblast formation (Jiang and Mendelson,
2003). In addition, Gcm1 activates the expression of syncytin-b;
because syncytin-a and syncytin-b promote cell fusion in
culture, they might also promote the formation of syncytiotro-
phoblasts (Knerr et al., 2005; Simmons et al., 2008; Dupressoir
et al., 2005). It appears that the overall effect of low oxygen
and subsequent HIF activity is to lower syncytiotrophoblast
numbers (Figure 4). In vivo, loss of HIF activity leads to a reduc-
tion in syncytiotrophoblasts because there is a loss of their
progenitors (diploid trophoblasts). However, in vitro when there
are sufficient progenitor trophoblasts, low oxygen and HIF
activity prevent formation of syncytiotrophoblasts; conversely,
when oxygen levels are high and HIF activity absent, syncytiotro-
phoblasts form (Cowden Dahl et al., 2005a).
In summary, placental development depends on an HIF-medi-
ated response to the low oxygen environment in which the
conceptus develops (Figure 4 and Table 1). Loss of HIF activity
not only stalls placenta formation before it has the capacity to
deliver oxygen or nutrients to the fetus, but has multiple other
roles: (1) it induces expression of integrins and ligands in the
allantois and chorion, facilitating chorioallantoic interaction and
branching morphogenesis within the developing labyrinthine
layer; (2) it induces expression of components of the MAP kinase
pathway, facilitating branching morphogenesis; (3) it induces
Mash2 expression, trophoblast proliferation, and spongiotro-
phoblast differentiation; and (4) it inhibits Gcm1 and Cyp19
expression and thus prevents syncytiotrophoblast formation.
This last point presents something of a paradox. Syncytiotropho-
blast formation relies on expression of the transcription factor
Gcm1, exit from the cell cycle, and cell fusion (Hughes et al.,
2004; Jiang and Mendelson, 2005; Knerr et al., 2005). Hypoxia
and HIF inhibit all these activities, so an increase in oxygen
concentration would promote syncytiotrophoblast formation.
How in an environment that is generally hypoxic do these syncy-
tiotrophoblasts get exposed to higher oxygen levels, facilitating
their differentiation and fusion? One explanation could be that
oxygen is carried by maternal blood, which is ‘‘embedded’’ in
an expanding domain of maternal blood sinuses resident in the
developing labyrinthine layer (Figure 3). This microenvironment
of higher oxygen could lead to cell cycle arrest and cell fusion
to form syncytiotrophoblasts (Jiang et al., 2000a). High oxygen
(or lack of hypoxia) derived from the maternal blood would also
provide a trigger for syncytiotrophoblasts to form adjacent to
maternal blood sinuses, and thus represents an exquisitely prac-
tical way of ensuring that these specialized trophoblasts form
where they are required. Moreover, it further illustrates the
ways in which oxygen can play a regulatory role in laying down
the cellular topography required for the establishment of a func-
tional placenta.
Placental insufficiency that develops as a result of reduced HIF
activity reduces cellular oxygen levels throughout the embryo
(Ryan et al., 1998). Consequently, studying the role that HIFs
play during normal embryonic development is confounded by
nonphysiological hypoxia generated as a result of an impaired
placenta. Confusion resulting from the effects of placental
insufficiency has been overcome with the use of tissue-specific
deletion strategies, which have demonstrated that Hif1a is
specifically required for development of the lung (Saini et al.,
2008) as well as the heart and bone (see below).DThe Effects of Hypoxia and HIF Activity on Heart
Development
The mammalian heart consists of four specialized chambers that
fulfill distinct roles. The atria collect blood and actively fill the
ventricles, and the ventricles propel blood through the pulmo-
nary and systemic vascular circuits. Valves and septa divide
the four chambers to prevent blood regurgitation and the mixing
of oxygenated and deoxygenated blood. The conduction system
directs electrical impulses throughout the heart and coordinates
chamber contraction. The coronary vasculature envelops and
penetrates the myocardium (muscle tissue of the heart), and
supplies oxygen and nutrients to this vital organ. Mouse heart
development takes places from E7.75–15 (Figure 5), and is
only covered briefly here. More detailed information can be
found in recent reviews that highlight the key features of the
process (Christoffels et al., 2004; Harvey, 2002; Hutson and
Kirby, 2007).
A number of cell types with different origins contribute to the
development of the heart. Cellular hypoxia and expression of
HIF components (Hif1a, Hif2a, and Arnt) occur during the heart
development process (Aitola and Pelto-Huikko, 2003; Jain et al.,
1998; Krishnan et al., 2008; Lee et al., 2001; Ream et al., 2008; Xu
et al., 2007), and HIF activity is absolutely required for normal
development of the heart (Table 2, Figures 5 and 6A). More
specifically, cardiac morphogenesis is abnormal in the absence
of Hif1a or Arnt, but not Hif2a or Hif3a. In addition, studies out-
lined below place the HIF target gene Vegfa in a central position
as a mediator of HIF function in heart development.
HIF Regulates Morphogenesis of the Developing Heart
As it forms, the mammalian heart undergoes a variety of
morphogenetic changes (Figure 5). Cardiac progenitor cells
(myocardial and endothelial) arise from mesoderm that coa-
lesces at the anterior of the embryo. These cells adopt a cres-
cent shape (E7.75), and then move ventrally and fuse into a linear
heart tube (E8.25). This tube is composed of endothelial cells
shrouded by a myocardial epithelium. The heart tube grows
by division of myocardial cells and by addition of cells to both
poles of the heart. Between E8.5 and E12 the heart undergoes
looping morphogenesis and chamber formation. Initially the
linear heart adopts a spiral form, and with further development
the inflow portion that receives venous blood (primitive common
atrium and sinus venosus) moves in an anterior and dorsal direc-
tion, bringing the inflow and outflow regions into proximity.
Chamber formation occurs through local expansion of the
myocardium. During the remodeling stage (E12.5–15), division
of the heart chambers by septation is completed and valves
ensure unidirectional blood flow. HIF activity is required for
normal heart morphogenesis. Loss of Hif1a or Arnt leads to ar-
rested morphogenesis at various stages from the cardiac cres-
cent stage through to chamber formation (Table 2, Figure 5)
(Adelman et al., 2000; Compernolle et al., 2003; Iyer et al.,
1998; Ryan et al., 1998). Many of the mechanisms involved in
these complex morphogenetic changes are not yet clear, and
so the mechanistic basis of HIF contribution also remains to
be established.
Loss of HIF Leads to Defective Development
of the Myocardium
During heart development, the myocardium undergoes regional
specialization (Figure 6A). Chamber formation requires theevelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 761
Figure 5. Heart Development and Loss of HIF Activity in Mouse
Stages of heart development (top) and the point at which cardiac morphogenesis arrests (circle) when HIF components are deleted or modified in mouse (bottom).
HIF components (Hif1a, Hif2a, Hif3a, and Arnt) are deleted or modified (Hif2a dn) in the whole conceptus, the embryo, vascular (vasc) endothelium, or myocar-
dium. OFT, outflow tract; V, ventricle; A, atrium; SV, sinus venosus; RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; Ao, aorta; P, pulmonary
artery; dn, dominant-negative.
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in zones that presage the formation of the atria and ventricles.
Subsequently, a sponge-like layer of myocytes (trabeculae)
develops at the lumenal surface of the forming chambers. These
are most prominent in the ventricles and are thought to increase
the surface area to maximize oxygen uptake by the myocardium.
At the same time, the outer layers of the ventricles thicken, as
a result of cell proliferation, and form the ventricular compact
layer. In addition the interventricular septum, which divides the
ventricles, forms through polarized growth of myocardial cells
at the junction of future left and right ventricles.
The myocardium is broadly hypoxic (%2% oxygen) at E9.5,
but by E13.5 the hypoxia is restricted to the myocardium of
the outflow tract, interventricular septum, and atrioventricular
cushions (Figure 2) (Krishnan et al., 2008; Lee et al., 2001;
Ream et al., 2008; Xu et al., 2007). Hif1a protein localization
mirrors the distribution of myocardial hypoxia during these
stages (Krishnan et al., 2008; Lee et al., 2001; Ream et al.,
2008; Xu et al., 2007). Immunohistochemical analysis with anti-
bodies directed against Hif2a and Arnt has not been reported,
but transcripts for Hif1a, Hif2a, and Arnt are present in the heart
in mouse from E9 to day 1.5 (Aitola and Pelto-Huikko, 2003; Jain
et al., 1998). In general, Hif1a is expressed in the myocardium of
the ventricles and atrioventricular cushions, Hif2a in endothelial
cells, and Arnt at low levels.
Development of the myocardium is severely disrupted in
embryos that lack Hif1a (Table 2). Myocardial trabeculation is
reduced or absent in embryos homozygous for either of two
Hif1a null alleles (Hif1atm1Rsjo and Hif1atm1Pec), and this is
consistent with the observed myocardial hypoplasia (Comper-762 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.nolle et al., 2003; Ryan et al., 1998). In striking contrast, mice
homozygous for a third null allele, Hif1atm1Jhu, display
a remarkable myocardial hyperplasia (Iyer et al., 1998). In each
of the Hif1a null alleles, exon 2, encoding the bHLH region of
Hif1a required for DNA binding and protein dimerization, is
deleted. However, neomycin is expressed using the phospho-
glycerokinase (PGK) promoter in the Hif1atm1Jhu allele, and
so it is conceivable that the myocardial hyperplasia that is
specific to this allele is dependent on the presence of PGK-
Neo in the Hif1a locus rather than the loss of Hif1a per se.
Myocardial hypoplasia also occurs in Arnt null embryos. Initially,
heart defects were not reported inArnt null embryos, which die at
E10.5 (Kozak et al., 1997; Maltepe et al., 1997). However, subse-
quent analysis of tetraploid chimeras generated with Arnt null
embryonic stem cells and wild-type (tetraploid) embryos
revealed a role for Arnt in heart development (Adelman et al.,
2000). Without the placental defect, embryo survival was
improved and hypoplasia of ventricular myocardium and
endocardial cushions was exposed. In addition to prolonged
embryo survival, revealing heart defects, it is also possible
that Arnt function was affected by modifiers, because Arnt
null conceptuses and tetraploid chimeras had distinct mouse
genetic backgrounds.
Loss of HIF Impacts the Vascular Endothelium
of the Heart
Vascular endothelial cells are intrinsic to heart formation, and
associate with both surfaces of the myocardium (Figure 6A).
The lumenal endocardium develops in proximity to the myocar-
dium from the cardiac crescent stage (E7.75), and the epicar-
dium that envelops the heart from E10–13.5 is the source of
Table 2. Morphological Heart Defects in Embryos Lacking Components of the HIF Transcription Complex
Gene Allele (Type) Mouse Model
(Cells Affected)
Lethal Key Aspects
of the Heart
Phenotype
Marker Gene
Expression
HIF Target
Gene Expression
Reference
Hif1a Hif1atm1Rsjo
(null)
homozygous
(all tissues)
E10 morphogenesis
arrested at looping
stage, small heart,
reduced endothelial
cells
CD31 - Ryan et al., 1998
Hif1a Hif1atm1Jhu
(null)
homozygous
(all tissues)
E10 morphogenesis
arrested at linear
heart tube stage,
myocardial
hyperplasia
Pecam1 - Kotch et al., 1999,
Iyer et al., 1998
Hif1a Hif1atm1Pec
(null)
homozygous
(all tissues)
E9.5–10 morphogenesis
arrested at various
stages, reduced/
absent trabeculation,
impaired neural crest
cell migration
Hnf3, p75, NP-1,
Nkx2-5, GATA-4,
bMHC, MLC2a,
SMA, desmin, Tgfb1,
Pdgfb, titin, Mef2c,
eHAND, Id2, Et1,
Sema3a, Ang1, Ang2,
Tie2, VE-cadherin
Anf, Vegfa, ETa,
Flk1, Flt1, Tie2
Compernolle
et al., 2003
Hif1a Hif1atm3Rsjo
(conditional
null)
Hif1atm3Rsjo/
Hif1atm1Jhu
and MLC2v-Cre
(ventricular
myocardium)
E11–12 morphogenesis
arrested at looping
stage, myocardial
hyperplasia,
increased myocyte
proliferation
cyclin D1, Cdk4,
p27, p21, Nkx2-5,
Tbx5, Mef2c
- Krishnan et al., 2008
Hif2a Flk1-HIFdn
(dominant
negative)
hemizygous
(endothelial
cells)
E11.5 morphogenesis
arrested at looping
stage, myocardial
hypoplasia, absent
trabeculation
Pecam1, Tie1,
VE-cadherin
Tie2 Licht et al., 2006
Arnt Arnttm1Mcs homozygous
all tissues)
by E10.5 E9.5 ‘‘appeared
normal’’
- Vegfa (embryo
and yolksac)
Maltepe et al., 1997
Arnt Arnttm1Mcs chimera
(embryo)
? hypoplastic
ventricular myocardium,
reduced endocardial
cushions, enlarged
atrio-ventricular
canal
- - Adelman et al., 2000
Allele symbols are standard (http://www.informatics.jax.org). Conceptus includes embryonic and extraembryonic tissues. The studies use various
gene names; Flt1 (Vegfr1), Kdr (Flk1, Vegfr2), Tek (Tie2), CD31 (Pecam1), eHAND (Hand1), Anf (Nppa), SMA (smooth muscle actin), and ETa (Ednra).
Gene expression level: equal, Roman lightface text; up, boldface; down, italics. Initial analysis of conceptuses homozygous for the Arnttm1Mcs null allele
did not describe placental defects (Maltepe et al., 1997). Hif2a (Epas) null embryos are defective in catecholamine homeostasis and heart function; they
do not have morphological heart defects (Compernolle et al., 2002; Peng et al., 2000; Tian et al., 1998). Hif3a null embryos survive but display enlarged
right atrium and ventricle post birth (Yamashita et al., 2008).
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blood to the heart muscle. The epicardium is also the major
source of the coronary microvasculature, which is embedded
in the myocardium and is continuous with the coronary vessels.
As stated, early in development the myocardium is generally
hypoxic. This is followed by a dramatic reduction in the number
of hypoxic cells between E13.5 and E15.5 in all regions except
the atrioventricular cushions; this reduction correlates with the
perfusion of the coronary vasculature following its connection
to the aorta at E14.5 (Xu et al., 2007). Loss of Hif1a disrupts
vascular endothelial development of the heart, and null embryos
have a severely reduced endocardium (Ryan et al., 1998);Dhowever, the embryos die at E10 so it was not established
whether Hif1a is required for formation of the epicardium or
subsequent formation of the coronary vasculature. It is likely
that Hif1a impacts formation of the coronary vasculature
because HIF activity is required for normal vascular development
in the embryo more generally, and angiogenesis in the embryo
and yolk sac are affected in the absence of Hif1a, Hif2a,
or Arnt (Compernolle et al., 2003; Duan et al., 2005; Iyer
et al., 1998; Kozak et al., 1997; Maltepe et al., 1997; Peng
et al., 2000; Ryan et al., 1998). For more information the reader
is directed to a recent appraisal of the effects of oxygen and
HIF on angiogenesis (Fraisl et al., 2009).evelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 763
Figure 6. Features of Heart Development Impaired with Loss of HIF
Activity
(A) Sectional representation of a normal mouse heart covering developmental
stages E9–12 with a summary of defects that occur with the loss of HIF activity.
Myocardium (red), epicardium (green dashed line), myocardial microvascula-
ture (green ), and endocardium lumenal layer (yellow) are shown. AVC, atrio-
ventricular canal; EC, endocardial cushion; IVS, interventricular septum; LA,
left atrium; LV, left ventricle; OFT, outflow tract; RA, right atrium; RV, right
ventricle.
(B) Model of endocardial cushion formation. E9–10: myocardial cells support
epithelial-to-mesenchymal transition. E10.5: mesenchymal cells populate
the endocardial cushion and consume oxygen to an extent that renders the
underlying myocardium hypoxic. Myocardial hypoxia results in vascular endo-
thelial growth factor (Vegfa) production and inhibition of epithelial-to-mesen-
chymal transition. Myocardium (red), hypoxic myocardium (blue), endocar-
dium (yellow), and mesenchymal cells (orange) are shown.
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and the Associated Vascular Endothelium?
Development of the myocardium and vascular endothelial cells
of the heart relies on their reciprocal interaction (Armstrong
and Bischoff, 2004; Grego-Bessa et al., 2007; Tomanek, 2005).
For this reason it is often difficult to establish if a gene is specif-
ically required in one tissue or the other for heart development.
Mice lacking HIF activity are defective in both myocardial and
endocardial development, raising the question of whether HIF
is required in the myocardium, the vascular endothelium, or
both. Several lines of evidence indicate that normal heart
morphogenesis requires Hif1a in the myocardium and not in764 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.the vascular endothelium of the heart. In addition, it is likely
that expression of the HIF target gene Vegfa in the myocardium
underpins the development of the vascular endothelium of the
heart because Vegfa receptors (Flt1 [Vegfr1] and Kdr [Vegfr2]),
expressed on vascular endothelial cells, affect survival, prolifer-
ation, migration, and differentiation. First, HIF activity is not
required in vascular endothelial cells of the heart because dele-
tion of Hif1a from these cells does not affect heart development
(Tang et al., 2004). This indicates that the heart defects in Hif1a
null embryos are likely to be derived from the loss of Hif1a in the
myocardium. In support of this, deletion of Hif1a from the
ventricular myocardium leads to an arrest of cardiac morpho-
genesis at the looping stage and to myocardial hyperplasia
(Krishnan et al., 2008). However, this finding needs verification
because the Hif1a null allele (Hif1atm1Jhu) that was used in
combination with theHif1a conditional null allele uniquely causes
myocardial hyperplasia; this is in contrast to the other Hif1a null
alleles, which cause hypoplasia (Table 2), as previously dis-
cussed. In this study, the vascular endothelium of the heart
was not examined; therefore, it is not clear what impact the
myocardial-specific deletion of Hif1a might have on the vascular
endothelial components of the heart during development. This is
addressed in part by another study that also examines the role of
Hif1a in the myocardium. Here, incomplete deletion ofHif1a from
myocardial cells results in reduced microvascularity of the
ventricular myocardium (Huang et al., 2004). This indicates that
Hif1a in the myocardium affects development of vascular endo-
thelial cells of the heart. It is likely that the HIF target Vegfa is
responsible for this non-cell-autonomous effect, and this is sup-
ported by the finding that incomplete deletion of Vegfa from the
developing myocardium results in myocardial and endothelial
defects (Giordano et al., 2001). Although not as extensively
studied in this context, it is also possible that another HIF target
gene, Ang2, is expressed in the myocardium and affects
vascular endothelial cell function because its receptor Tek
(Tie2) functions in vascular endothelial cells (Simon et al., 2008;
Suri et al., 1996). Ang2 null embryos exhibit poorly developed
myocardium and endocardium, like those null for Hif1a, and so
the HIF1-Ang2 axis in the myocardium could also contribute to
the heart defects in Hif1a null embryos.
Despite the evidence that HIF1 only acts in the myocardium
during heart development, a function for HIF in vascular
endothelial cells of the heart cannot be completely excluded.
One study tested the role of HIF activity in endothelial cells by
expressing a dominant-negative Hif2a (HIFdn) in vascular endo-
thelial cells (Licht et al., 2006). HIFdn inhibits expression of HIF1
and HIF2 target genes in cultured cells, probably via binding to
Hif1a, Hif2a, and Arnt. Embryos expressing HIFdn in endothelial
cells develop heart defects that include a thin myocardium,
a disorganized endocardium, and poorly established trabecula-
tion. These results suggest that HIF transcriptional activity might
be required in endothelial cells for normal heart development.
Loss of either Hif1a from endothelial cells or Hif2a from the
whole conceptus does not impair heart development (Table 2),
but it is possible that HIF1 and HIF2 are performing redundant
functions, and therefore only the loss of both would lead to
a phenotype. Alternatively, HIFdn may interfere with Hif1a and
Hif2a functions that are independent of Arnt, since Hif1a
and Hif2a each also bind to other factors such as Notch1 and
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could test this possibility.
In summary, it is likely that Hif1a is required in the myocardium
for normal myocardial and vascular endothelial development,
and that Vegfa mediates the non-cell-autonomous function of
HIF in vascular endothelial cells. Additional examples of myocar-
dial-specific deletion of Hif1a will further clarify the situation.
HIF Is Required for Migration of Neural Crest Cells
Neural crest cells also contribute to heart development, and are
affected by loss of Hif1a (Compernolle et al., 2003; Jiang et al.,
2000b). Cardiac neural crest cells contribute to the outflow tract
from E9.5, and if their numbers are reduced the outflow tract is
misaligned by E12.5 and does not divide into the aorta and the
pulmonary artery (Hutson and Kirby, 2007; Jiang et al., 2000b).
Cardiac neural crest cells also provide all the parasympathetic
innervation to the heart and thus are associated with maturation
of the cardiac conduction system.
In Hif1a null embryos, neural crest cells form but do not
migrate ventrally into the head mesenchyme and branchial
arches (Compernolle et al., 2003). Neural crest cell migration
is dependent on interaction between endothelin1, expressed
by non-neural-crest cells in the branchial arches, and its receptor
(Ednra), expressed by the neural crest cells (Hutson and Kirby,
2007). In the absence of Hif1a, expression of endothelin1 is up-
regulated, and this likely explains the observed defects in neural
crest cell migration. Although Hif1a null embryos die before
neural crest cells contribute to the heart (Table 2), their disrupted
migration makes it highly likely that neural-crest-dependent
heart development would be impaired by the loss of Hif1a. The
role of Hif1a in cardiac neural crest cell migration could be ad-
dressed by specific deletion of Hif1a in neural crest cells (using
Wnt1-Cre), and this would determine whether Hif1a acts in
neural crest cells or plays a role in the mesenchyme to non-
cell-autonomously direct neural crest function.
Hypoxia and HIF Are Features of Endocardial Cushion
Formation
Myocardial hypoxia is a feature of endocardial cushion formation
and there is evidence that loss of HIF activity affects cushion
development. Endocardial cushions are swellings that form on
the lumenal surface of the heart tube and give rise to the septa
and valves (see Figure 6A) (Armstrong and Bischoff, 2004).
They form in association with nonchamber myocardium and
initially act to direct independent patterns of blood flow for the
pulmonary and systemic circuits. In the atrioventricular canal,
endocardial cushions are the precursors of the tricuspid and
mitral valves, whereas in the outflow tract they form a scaffold
for the aorticopulmonary septum that divides the outflow
tract into the aorta and pulmonary artery and forms the aortic
and pulmonary valves. Endocardial cushions develop from
E9–10.5, and from E11 they are remodeled to form valves.
Initially ECM (produced by the myocardium) is deposited
between the myocardium and the endocardium, resulting in
a swelling. Next, endocardial cells undergo epithelial-to-mesen-
chymal transition, producing mesenchymal cells that populate
the ECM-rich swellings. Epithelial-to-mesenchymal transition
then ceases, and signals from the endocardium promote remod-
eling and valve formation.
The hypoxia-HIF-Vegfa alliance is involved in development of
the endocardial cushions in a few different ways. First, cushionDmyocardium is hypoxic from E11.5–14.5 (Xu et al., 2007 and
Figures 2B and 2C) (earlier stages have not yet been examined).
Second, epithelial-to-mesenchymal transition of the endocar-
dium is inhibited if levels of the HIF target gene Vegfa are altered
or if cushion explants are cultured in low oxygen (Armstrong and
Bischoff, 2004; Dor et al., 2001; Dor et al., 2003). Other studies
focused on Vegfa and nuclear factor of activated T cells cyto-
plasmic 1 (Nfatc1) indicate that Vegfa, produced by the myocar-
dium, activates Kdr (Vegfr2) on endocardial cells, leading to
nuclear localization of the transcription factor Nfatc1 and endo-
cardial cell proliferation. Endocardial proliferation then facilitates
epithelial-to-mesenchymal transition, which is necessary for
mesenchymal cells to populate the developing cushion (Johnson
et al., 2003). Although HIF plays a significant role in endocardial
cushion formation, it is important to note that it is not the only
regulator of Vegfa expression (Chang et al., 2004), and that
factors other than Vegfa affect epithelial-to-mesenchymal transi-
tion in endocardial cushion formation. Interestingly, some of
these factors are also linked to Hif1a: transforming growth factor
b1, Notch1, b-catenin, and epidermal growth factor (Armstrong
and Bischoff, 2004; Gustafsson et al., 2005; McMahon et al.,
2006; Wang et al., 2009).
Why does the myocardium underlying the developing endocar-
dial cushion become hypoxic, when adjacent myocardium does
not? One possible explanation is illustrated in Figure 6B. Initially,
when endocardial cushions are largely filled with ECM and few
to no cells, the underlying myocardium is readily supplied
with oxygen as blood passes between the developing cushions.
As additional mesenchymal cells populate the endocardial
cushions, they increasingly consume oxygen, and the cushion-
associated myocardium is exposed to lower oxygen concentra-
tions. Thus, cell density in the endocardial cushion inversely
correlates with oxygen concentration. Moreover, oxygen deple-
tion feeds back to prevent further epithelial-to-mesenchymal
transition by triggering HIF activity to activate Vegfa expression.
The effects of hypoxia on epithelial-to-mesenchymal transforma-
tion in the endocardial cushion could potentially serve as a para-
digm for other locations in the embryo where epithelial-to-
mesenchymal transitions occur.
In sum, hypoxia and HIF activity are features of normal heart
development. Despite recent advances in our understanding,
a number of key questions remain, including: to what extent
are the heart defects secondary to impaired hemodynamics?
What features of heart development specifically require HIF
activity? What are the direct molecular effectors of HIF activity?
Answering these questions will be crucial to understanding heart
development, and will be best addressed by deleting HIF activity
from myocardial progenitors (rather than just ventricular myocar-
dium), or from epicardial cells or neural crest cells using appro-
priate Cre recombinase mouse lines such as Nkx2-5-Cre,
Gata5-Cre, or Wnt1-Cre (Jiang et al., 2000b; Merki et al., 2005;
Saga et al., 1999; Stanley et al., 2002).
Changing Oxygen Levels Impact Endochondrial
Bone Formation
Endochondrial bone formation involves a progression from
condensed mesenchyme to a bipotent osteochondro progen-
itor, to cartilage formation (chondrogenesis), and then to bone
formation (osteogenesis) (Figure 7) (Karsenty, 2008). Thisevelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 765
Figure 7. Hypoxia Directs Endochondrial Bone Formation
(A) Diagrammatic representation of chondrocyte proliferation and differentiation in the fetal growth plate of long bones (proximal at top). The vertical line depicts
the extent of cellular hypoxia. Mesenchymal condensations differentiate into round and then columnar chondrocytes that proliferate and express collagen type II.
As chondogenesis progresses, chondrocytes exit the cell cycle, undergo hypertropy, express collagen type X, direct mineralization of ECM, attract blood vessels,
and then undergo apoptosis.
(B) Lineage relationships (black arrows) in endochondrial bone formation show condensing mesenchyme forming osteochondro progenitor cells, which differ-
entiate under hypoxic conditions into chondrocytes or into osteoblasts once hypoxia is relieved. Hypoxia induces the expression of Sox9, Twist1, and Nfatc1,
and inhibits Runx2 expression. Green arrows show stimulatory, and red lines inhibitory, interactions.
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brae, relies on bone forming on a template generated by the
cartilage-producing chondrocytes. The chondrocytes that form
from these progenitors undergo a program of proliferation,
hypertrophy, ECM deposition, and subsequent apoptosis, which
makes way for the bone-depositing osteoblasts. In mice the axial
skeleton (vertebrae and ribs) forms from E10–18.5. The limbs
also develop during this time with mesenchymal condensation
occurring in the limb buds from E10.5 (Wright et al., 1995). There
are a number of recent reviews that provide excellent appraisals
of endochondrial bone formation (Dai and Rabie, 2007; Hall et al.,
2006; Karsenty, 2008).
Many stages of endochondrial bone formation are sculpted by
the availability of oxygen and the HIF-mediated transcriptional
responses. The roles of hypoxia and HIF activity in endochon-
drial bone formation have been studied primarily in the context
of the limb. Hypoxia (%2% oxygen) and a HIF-mediated
response are apparent at the earliest stages (E10.5–12.5) of
bone development in the mouse embryo (Amarilio et al., 2007;
Provot et al., 2007). Moreover, tissue-specific deletion demon-
strates that Hif1a is required during endochondrial bone
formation for chondrogenesis (Amarilio et al., 2007; Provot
et al., 2007).
Hypoxia and HIF Affect Mesenchyme Condensation
and Chondrocyte Formation
The earliest stages of endochondrial bone formation require the
HIF-mediated response to hypoxia. The limb anlage, which is766 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.highly vascularized, undergoes vascular remodeling, producing
avascular areas that subsequently undergo mesenchymal
condensation (Feinberg et al., 1986). It appears that hypoxia
presages and therefore might also induce mesenchyme conden-
sation. It also is possible that increasing cell density in an avas-
cular environment would promote cellular hypoxia. As yet,
specific studies to address these possibilities have not been
performed. The condensing mesenchyme of the mouse limb
bud and axial skeleton are hypoxic and express Hif1a protein
(Amarilio et al., 2007; Provot et al., 2007). Deletion of Hif1a
from E9.5 in limb bud mesenchyme using Prx1-Cre expression
produces viable mice with dramatically shortened limbs (Amari-
lio et al., 2007; Provot et al., 2007). Because condensation of
mesenchyme still occurs, the authors argued that mesenchymal
condensation presages the hypoxia rather than being reliant on
it. However, because the deletion of Hif1a only reached 75%,
there could have been sufficient Hif1a to respond to the cellular
hypoxia induced by the vascular remodeling prior to condensa-
tion. Complete deletion ofHif1a from this mesenchyme would be
needed to address this question definitively.
Hypoxia and HIF Are Required for Chondrogenesis
Newly formed chondrocytes lie within the growth plates, which
are located at the ends of long bones and are where growth
occurs. Within the growth plate, distally located chondrocytes
are round and proliferative; they then become organized into
columns more proximally (Figure 7). These proliferating chon-
drocytes express angiogenic inhibitors (Moses et al., 1999)
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type II collagen. Hypoxic cells and Hif1a are localized to the
proximal growth plate where chondrocytes are undergoing
proliferation (Schipani et al., 2001). As chondrogenesis prog-
resses, chondrocytes exit the cell cycle, hypertrophy, and
then undergo apoptosis. The hypertrophic chondrocytes are
drivers of bone growth; they express collagen type X (which is
subsequently replaced by bone and marrow), act as a regulatory
cell type directing mineralization of the surrounding ECM,
attract blood vessels through Vegfa expression, and attract
chondroclasts (from the macrophage lineage) to digest ECM.
In addition, before undergoing apoptosis hypertrophic chondro-
cytes instruct adjacent perichondrial cells to become osteo-
blasts. Osteoblasts differentiate on the plates of mineralized
cartilage between columns of hypertrophic chondrocytes and
lay down delicate spicules of woven bone (primary trabeculae),
while osteoclasts remove mineralized ECM. Only the distal
portion of the hypertrophic zone is hypoxic, and the transition
in the growth plate from proliferating chondrocytes to hypertro-
phic chondrocytes coincides with a loss of hypoxia (Schipani,
2005).
Deletion of Hif1a early or late in chondrogenesis leads to
massive cell death in the proximal limb bones (stylopod and
zeugopod) and severe limb shortening (Schipani et al., 2001;
Amarilio et al., 2007). However, the distal limb bones of the
autopod are spared this cell death and instead exhibit delayed
chondrogenesis (Schipani et al., 2001; Amarilio et al., 2007).
This difference might reflect the variation in bone shape and
thickness, which is likely to affect cellular oxygen concentrations
(Provot et al., 2007). It also allowed the role of Hif1a in chondro-
cyte differentiation to be studied in the autopod, and revealed
a delay in chondrogenesis (Provot et al., 2007). Normally,
mesenchymal condensations of the developing limb differen-
tiate into chondrocytes by E13.5, but in the absence of Hif1a,
undifferentiated mesenchyme persists in the autopod. Differen-
tiation to chondrocytes does still occur but it is clearly delayed,
indicating that Hif1a is required for timely chondrocyte forma-
tion. Subsequent chondrocyte hypertrophy is also delayed,
perhaps because there are fewer proliferative chondrocytes,
or because Hif1a is specifically required for chondrocyte hyper-
trophy. This Hif1a-dependent delay in chondrogenesis is most
apparent at joints (Amarilio et al., 2007; Provot et al., 2007).
During joint formation the avascular perichondrium thickens,
the underlying chondrocytes become hypoxic, and Hif1a protein
is stabilized. The joints of the ankle and wrist, which are the most
severely affected by the loss of Hif1a, are the regions in the
developing limb with lowest levels of oxygen (Provot et al.,
2007).
In sum, normal development of limb bones requires Hif1a. In
its absence, the progression from condensed mesenchyme to
proliferating chondrocytes and then to hypertrophic chondro-
cytes is delayed, leading to impaired chondrogenesis. More-
over, substantial cell death occurs in the growth plate, demon-
strating that Hif1a is needed for chondrocyte survival. There are
a number of potential mechanisms that could contribute to
chondrocyte death in Hif1a mutants. Hif1a might act as
a survival factor by activating the expression of Vegfa, which
is required for chondrocyte survival (Dai and Rabie, 2007).
Alternatively, Hif1a might promote the survival of chondrocytesDthrough their dependence on ECM interaction. Hypoxia and
Hif1a enhance the deposition of ECM (Pfander et al., 2003)
by increasing the expression of procollagen hydroxylases
(P4ha1, P4ha2, Plod1, and Plod2), which are necessary for
the processing and secretion of collagen (Hofbauer et al.,
2003; Takahashi et al., 2000). Thus, in the absence of Hif1a,
a reduction in the ECM may lead to cell death. In a related
manner reduced expression of procollagen hydroxylase leads
to the accumulation of large amounts of unprocessed collagen,
and the resultant unfolded protein response could trigger endo-
plasmic reticulum stress signaling (ERSS) and subsequently cell
death (Wouters and Koritzinsky, 2008; Lai et al., 2007). Indeed,
ERSS occurs and endochondrial bone formation is delayed in
a mouse model where a mutant form of collagen type X is
produced (Tsang et al., 2007). Another possibility is that
impaired metabolic adaptation to hypoxia might promote chon-
drocyte apoptosis (Schipani, 2006). For example, Hif1a nor-
mally activates expression of PGK in the growth plate. PGK is
a key enzyme of the anaerobic glycolysis pathway, so its
absence might trigger apoptosis. Finally, autophagy represents
an adaptive response to hypoxia. HIF inhibits mTOR and mTOR
inhibits autophagy, so loss of Hif1a can lead to unrestrained au-
tophagy, resulting in apoptosis (Srinivas et al., 2009). Deter-
mining the molecular trigger for apoptosis in this context will
require in-depth analyses, and may well reveal that more than
one of these programs is at play in directing cell death in the
absence of Hif1a.
Hypoxia-Dependent Transcriptional Network
in Bone Formation
Further insight into the role that oxygen and Hif1a play in endo-
chondrial bone formation requires an appreciation of the
broader transcriptional network involved. The transcriptional
landscape of endochondrial bone formation is built around two
transcription factors: Sox9, which is required for the formation
of cartilage-forming chondrocytes (Akiyama et al., 2002; Bi
et al., 1999), and Runx2, which is required for bone-forming
osteoblasts and for chondrocyte maturation (Lefebvre and
Smits, 2005) (Figure 7). Hypoxia activates Sox9 expression
and leads to the inhibition of Runx2 expression. As a result,
chondrogenesis and osteogenesis are spatially and temporally
separated during bone formation by differing oxygen concentra-
tions. Sox9, a DNA-binding protein of the high mobility group
(HMG) family, is expressed in condensed mesenchyme and in
proliferating chondrocytes (Lefebvre and Smits, 2005). Runx2
is a member of the Ig-loop family and is expressed in condensed
mesenchyme and prehypertrophic chondrocytes, and at high
levels in the osteoblast lineage (Karsenty, 2008; Lefebvre and
Smits, 2005). Condensing mesenchyme becomes hypoxic,
leading to Hif1a-dependent activation of Sox9 transcription
and the formation of osteochondro progenitor cells (Amarilio
et al., 2007). Sox9 expression, supported by hypoxia, drives
these progenitors to differentiate into proliferating chondrocytes
(Akiyama et al., 2002; Bi et al., 1999). At the same time Sox9
inhibits these proliferating chondrocytes from differentiating
into hypertrophic chondrocytes (Bi et al., 1999). In addition, by
inhibiting Runx2 expression Sox9 also prevents the formation
of hypertrophic chondrocytes (Zhou et al., 2006). More distally,
release from hypoxia promotes a switch in expression from
Sox9 to Runx2, which causes proliferating chondrocytes toevelopmental Cell 17, December 15, 2009 ª2009 Elsevier Inc. 767
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Concurrently, although hypoxia promotes early progression
through the chondrocyte lineage with the formation of prolifer-
ating chondrocytes, it inhibits the development of the osteo-
blastic lineage. This inhibition occurs because osteochondro
progenitors require Runx2 expression for osteoblast formation,
and hypoxia inhibits Runx2 expression. Inhibition of Runx2
expression by hypoxia is indirect, because Hif1a directly acti-
vates the expression of Twist1 and Nfatc1, which in turn inhibit
Runx2 transcription (Seifert et al., 2008) (Yang et al., 2008)
(Figure 7).
Endochondrial bone formation differs from heart development
where the hypoxia-HIF-Vegfa nexus is central to morphogen-
esis. In endochondrial bone formation, hypoxia and HIF-depen-
dent Sox9 and Runx2 expression directly drive the changing
cellular landscape, and Hif1a-dependent Vegfa appears to act
as a chondrocyte survival factor rather than a promotor of angio-
genesis (Schipani, 2006). The hypoxic and Vegfa-expressing
proximal growth plate remains avascular because proliferating
chondrocytes express antiangiogenic factors, and the ECM
captures the Vegfa, rendering it latent (Hall et al., 2006; Moses
et al., 1999). Vascularization of the growth plate occurs more
distally in response to relatively higher Vegfa levels, induced by
Runx2 in hypertrophic chondrocytes, and presumably also by
Vegfa that is released as the ECM is broken down (Dai and Rabie,
2007; Lian et al., 2006).
Perspectives
This review documents the occurrence of cellular hypoxia,
describes the function of HIF during development, and synthe-
sizes the molecular and cellular aspects of hypoxia and HIF
in the mouse embryo and placenta. As a result it is possible to
identify elements of hypoxia-HIF action that are both distinct
and recurrent during development. In addition, this review
demonstrates that the timing of hypoxia and release from it,
as well as its spatial nature, are key to tissue morphogenesis.
Finally, it raises the issue of whether the HIF-mediated response
to physiological hypoxia differs from the nonphysiological
response.
By considering the different ways in which hypoxia-HIF action
contributes to development, it is possible to identify elements
that are distinct and those that are recurrent. Hypoxia and HIF
drive developmental morphogenesis by directing cell differentia-
tion and cell behavior. Although cell differentiation and behavior
are not always easily separable, it appears that HIF-dependent
expression of transcription factors directs cell differentiation,
while its promotion of Vegfa signaling affects cell behavior. For
example, direct HIF-dependent expression of the transcription
factors Mash2 and Sox9 promotes differentiation of spongiotro-
phoblasts in the placenta and chondrocytes in bone, respec-
tively. Moreover, indirect effects of hypoxia and HIF on the
transcription factors Gcm1 and Runx2 correspondingly inhibit
syncytiotrophoblast formation in the placenta, and chondrocyte
hypertrophy and osteoblast formation in bone. In comparison,
the HIF-dependent expression of the secreted factor Vegfa
primarily affects the behavior of vascular endothelial cells by
impacting their survival, proliferation, and migration (Hall et al.,
2006). In doing so it affects angiogenesis, which in terms of the
systems discussed in this review, is a feature of fetal vascular768 Developmental Cell 17, December 15, 2009 ª2009 Elsevier Inc.development in the labyrinthine layer of the placenta and vascu-
larization of the heart. In addition, Vegfa released by the myocar-
dium affects endothelial cells of the endocardium, and thus
regulates two processes: epithelial-to-mesenchymal transition
during endocardial cushion formation, and myocardial trabecu-
lation with Vegfa-activated endocardial cells signaling back to
the Vegfa-producing myocardium (Ferrara et al., 1996; Lam-
brechts and Carmeliet, 2004). Furthermore, Vegfa signaling
also appears to act on nonvascular endothelial cells, because
it promotes the survival of proliferating chondrocytes during
bone formation.
Development is driven by spatiotemporal differences in gene
expression and cell behavior. HIF activity during development
is controlled in space and time by the availability of oxygen.
This is especially evident when hypoxia-induced HIF activity is
switched between on and off states, as seen in the placenta,
the endocardial cushion, and bone formation. In the placenta,
oxygen from the maternal blood sinuses releases trophoblasts
adjacent to these sinuses from hypoxia, allowing them to
differentiate into syncytiotrophoblasts. During formation of
the endocardial cushion, acquisition of myocardial hypoxia
leads to inhibition of epithelial-to-mesenchymal transition of
the endocardium, in response to high cushion cell density.
Endochondrial bone formation requires that chondrogenesis
proceed osteogenesis because bone forms in the ECM scaffold
laid down by the chondrocytes. Hypoxia and then release
from it drives this progression, because the initial hypoxia is
required for chondrogenesis, and subsequent oxygenation, for
osteogenesis.
Some 200 HIF target genes have been described in various
cell types cultured under low-oxygen conditions (Manalo et al.,
2005; Wenger et al., 2005). It seems unlikely that all these genes
would be transcribed in vivo in cells exposed to either physiolog-
ical or nonphysiological hypoxia. It is more plausible that the
transcriptional response to hypoxia would be context-depen-
dent; that is, it would depend on the cell type involved and the
extent and duration of hypoxia. There is some initial evidence
that physiological hypoxia in the conceptus induces the expres-
sion of distinct transcription factors in a cell-type-dependent
manner; Mash2 is expressed in diploid trophoblasts of the
placenta, and Sox9, in proliferating chondrocytes during bone
formation. Hypoxia and HIF-induced expression of Mash2 and
Sox9 do not seem to be features of nonphysiological hypoxia.
Despite these examples of context-dependent responses to
physiological hypoxia, it is also clear that some genes are tran-
scribed by HIF in response to both physiological and nonphysio-
logical hypoxia in a variety of contexts in vivo. Vegfa is a case in
point; it is induced during development, and also in response to
ischemia in the mouse brain and heart (Bernaudin et al., 2002;
Das and Maulik, 2006). In conclusion, there is evidence suggest-
ing that HIF responds to hypoxia in a context-dependent
manner, and understanding the details of this awaits the collec-
tion of a significant amount of additional data.
Nonphysiological Hypoxia Adversely Affects Embryonic
Development
The hypoxia-dependent HIF transcription system has evolved
the capacity to work with the physiological hypoxia present
during normal embryonic development, and indeed, uses it to
sculpt the embryo. However, it is important to note that this
Developmental Cell
Reviewsystem is limited in its ability to respond to nonphysiological
hypoxia—that is, enhanced and/or spatially extended hypoxia—
during development. For example, inducing nonphysiological
hypoxia in mouse and rabbit embryos leads to a variety of
developmental defects that occur in places including the heart
and vertebral column (Clemmer and Telford, 1966; Loder et al.,
2000; Ream et al., 2008). We are now at a point in our under-
standing of the effectors of the hypoxic response where we can
begin to elucidate how this nonphysiological hypoxia induces
morphological changes.
Nonphysiological hypoxia also results from placental insuffi-
ciency (Bozec et al., 2008; Navankasattusas et al., 2008;
Sparrow et al., 2009), and it appears that the timing and extent
of the deficiency influences the type of developmental process
that is disrupted. For example, placental insufficiency at midges-
tation due to the loss of retinoblastoma (Rb) leads to midgesta-
tion embryonic lethality with widespread developmental defects
and aberrant apoptosis and cell proliferation (Jacks et al., 1992;
Lee et al., 1992). The defects in the embryo are due entirely to
placental insufficiency, because Rb null embryos survive gesta-
tion when supported by a wild-type placenta (Wu et al., 2003).
Placental insufficiency at a later stage (E14.5) resulting from
loss of Cited1 in the placenta specifically does not lead to
embryo lethality, but rather to a more restricted developmental
defect involving hypoxia-induced apoptosis and defective corti-
comedullary patterning in the kidneys at E17.5 (Sparrow et al.,
2009). Eighty percent of the mice die at birth, and survivors
have a deficiency in the ability to concentrate urine. In a third
example, placental insufficiency at the end of gestation (E18.5)
leads to hypoxia in the long bones of Fosl2 (Fra-2) null mice
(Bozec et al., 2008), resulting in bone defects through increased
osteoclast size and number.
Crosstalk between Hypoxia and HIF with Signaling
Pathways in Development
In this review I have only discussed activity of the HIF complex
(Hif1a or Hif2a with Arnt) in relation to transcriptional activation
of hypoxia-responsive genes, but components of the HIF tran-
scription complex also interact with other signaling pathways
that are active during development. For example, Hif1a binds
to the activated intracellular domain of the Notch receptor
(NICD) (Gustafsson et al., 2005). NICD complexes with the
DNA-binding protein CSL to activate transcription of target
genes. Interaction between Hif1a and NICD stabilizes NICD,
and potentiates the transcriptional activation of target genes
such as the transcription repressors Hes1 and Hey2. This inter-
action, which has been well reviewed (Poellinger and Lendahl,
2008; Sainson and Harris, 2006), presents the exciting possibility
that Notch signaling is positively modulated in hypoxic regions
during development. As Notch signaling is a major factor in
embryonic development, the effects of this crosstalk could
potentially be extensive. A second point of interaction between
these pathways involves binding of Fih to the Notch receptor
(Coleman et al., 2007; Linke et al., 2008). Fih has a greater affinity
for Notch than for Hif1a, so the presence of Notch may reduce
asparagine hydroxylation of Hif1a and thus indirectly enhance
Hif1a-mediated transcriptional activation of HRE-containing
genes (Poellinger and Lendahl, 2008).
Hif1a also interacts with b-catenin and thereby connects
hypoxia to Wnt signaling (Kaidi et al., 2007; Lim et al., 2008).DWnt-dependent transcription relies on dimerization of b-catenin
with the transcription factor T cell factor 4 (Tcf4). Under hypoxic
conditions Hif1a interacts with b-catenin. Additionally, hypoxia
can cause destabilization of b-catenin because Hif1a binds
human arrest defective 1 (hARD1), which acetylates and stabi-
lizes b-catenin. In both cases, either HIF1a or hypoxia limits
interaction between b-catenin and Tcf4, resulting in reduced
transcription of the Wnt target gene c-Myc and cell growth
arrest. Conversely, dimerization of Hif1a and b-catenin under
hypoxic conditions potentiates transcription of Hif1a target
genes including Vegfa (Kaidi et al., 2007).
These exciting examples of crosstalk reveal additional
avenues through which hypoxia and Hif1a can impact cell
behavior. However, the findings regarding Notch and Wnt rely
on protein overexpression, and those concerning Wnt signaling
were performed using cancer cell lines and not embryos.
Their relevance to embryonic development therefore awaits
validation.
Conclusion
The primary function of the HIF transcriptional system is to
protect organisms against hypoxia. In mammalian embryos,
which develop in a low-oxygen environment, HIF has been
co-opted to play a role in embryo morphogenesis. Recently
our understanding of the role that hypoxia and HIF activity
play in embryo and placenta morphogenesis has increased
significantly. However, we still need to define specific molecular
interactions and outcomes, and link these with their cellular
responses. To achieve this goal, tissue- and stage-specific
gene deletions in combination with tissue culture studies will
be essential. In particular we need to elucidate the primary roles
of HIF activity in the developing cardiovascular system and
placenta. These are key sites of HIF activity, and if either site
is compromised, the whole of embryonic development is
impaired. Next, a systems biology approach is needed to iden-
tify direct targets of the HIF1 and HIF2 transcription complexes.
Understanding the roles of HIF targets in the context of develop-
ment will be a real triumph. What is the goal of a comprehensive
molecular and cellular understanding of HIF activity in embry-
onic development? At its simplest, it is to understand birth
defects; more broadly, it is to provide an intellectual and molec-
ular framework for stem cell manipulation and regenerative
medicine.
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